Treating Myocardial Infarction in the Post-GUSTO Era Daniel Mark Current Opinion 25 November 2012 Pages: 473 - 477
The Impact of User Charges on the Consumption of Drugs Ulf-G. GerdthamMagnus Johannesson Leading Article 25 November 2012 Pages: 478 - 483
Is There Scope for Improving the Cost-Effective Prescribing of Nonsteroidal Anti-Inflammatory Drugs? Karen BloorAlan Maynard Review Article 25 November 2012 Pages: 484 - 496
Clinical and Cost Considerations in the Pharmacotherapy of Vulvovaginal Candidiasis Ignatius W. Fong Review Article 25 November 2012 Pages: 497 - 505
Statistical Analysis in Pharmacoeconomic Studies Douglas Coyle Review Article 25 November 2012 Pages: 506 - 516
A Cost Analysis of Alprostadil in Liver Transplantation Dean G. SmithKeith S. HenleyI. Douglas McLaren Original Research Article 25 November 2012 Pages: 517 - 524
Estimating the Cost Effectiveness of Atovaquone versus Intravenous Pentamidine in the Treatment of Mild-to-Moderate Pneumocystis carinii Pneumonia Gary A. ZarkinMohan V. BalaMichael N. Dohn Original Research Article 25 November 2012 Pages: 525 - 534
Canadian Guidelines for Economic Evaluation of Pharmaceuticals George W. TorranceDavid BlakerTheresa Firestone Special Article 25 November 2012 Pages: 535 - 559